ID
25306
Descrizione
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Keywords
versioni (7)
- 31/08/17 31/08/17 -
- 31/08/17 31/08/17 -
- 31/08/17 31/08/17 -
- 04/09/17 04/09/17 -
- 04/09/17 04/09/17 -
- 04/09/17 04/09/17 -
- 12/09/17 12/09/17 -
Caricato su
31 agosto 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
laboratory collections - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
laboratory collections - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
Similar models
laboratory collections - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
C0018941 (UMLS CUI-2)
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])